Nitrol and Novalgin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrol (nitroglycerin) and Novalgin (metamizole). Common drug interactions include urinary tract infection bacterial among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrol and Novalgin. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrol?

Nitrol has active ingredients of nitroglycerin. eHealthMe is studying from 3,069 Nitrol users. Check the latest studies of Nitrol.

What is Novalgin?

Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 10,177 Novalgin users. Check the latest studies of Novalgin.



On Jul, 20, 2026

51 people who take Nitrol and Novalgin together, and have interactions are studied.

Nitrol and Novalgin drug interactions.

What are the common drug interactions of Nitrol and Novalgin, by gender? *:

female:

  1. Urinary tract infection bacterial
  2. Vomiting
  3. Colitis (inflammation of colon)
  4. Multi-organ failure (multisystem organ failure)
  5. Pneumonia
  6. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
  7. Blood pressure increased
  8. Conjunctivitis (pink eye)
  9. Inflammatory marker increased
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cold sweat
  3. Hypertension (high blood pressure)
  4. Hypokalaemia (low potassium)
  5. Anaemia (lack of blood)
  6. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  7. Aphasia (damage to the parts of the brain that control language)
  8. Blood glucose increased
  9. Cardiac failure
  10. Cervicobrachial syndrome (pain in neck and arm with changing location)

What are the common drug interactions of Nitrol and Novalgin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  2. Blood glucose increased
  3. Cervicobrachial syndrome (pain in neck and arm with changing location)
  4. Disturbance in attention
  5. Dizziness
  6. Fatigue (feeling of tiredness)
  7. Glycosylated haemoglobin increased
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Overdose
  10. Conjunctivitis (pink eye)

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Anaemia (lack of blood)
  3. Leukopenia (less number of white blood cells in blood)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Thrombocytosis
  7. Urinary tract infection bacterial
  8. Vomiting
  9. Pneumonia
  10. Aphasia (damage to the parts of the brain that control language)

What are the existing conditions these people have? *

  1. Constipation: 21 people, 41.18%
  2. Sleep Disorder: 16 people, 31.37%
  3. Neuropathy Peripheral (surface nerve damage): 16 people, 31.37%
  4. Dry Eyes (lack of adequate tears): 16 people, 31.37%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 15 people, 29.41%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 15 people, 29.41%
  7. Type 2 Diabetes: 6 people, 11.76%
  8. High Blood Pressure: 6 people, 11.76%
  9. Joint Pain: 5 people, 9.80%
  10. Stress And Anxiety: 5 people, 9.80%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrol and Novalgin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitrol and Novalgin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Novalgin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novalgin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and metamizole (the active ingredients of Nitrol and Novalgin, respectively), and Nitrol and Novalgin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: